Susquehanna International Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,808,500
Closed -$180M 11307
2019
Q3
$180M Sell
1,808,500
-1,079,800
-37% -$103M 0.06% 265
2019
Q2
$267M Sell
2,888,300
-3,197,500
-53% -$304M 0.1% 170
2019
Q1
$574M Buy
6,085,800
+804,800
+15% +$70.4M 0.24% 60
2018
Q4
$338M Buy
5,281,000
+244,400
+5% +$18M 0.13% 119
2018
Q3
$451M Sell
5,036,600
-1,977,900
-28% -$175M 0.15% 93
2018
Q2
$557M Buy
7,014,500
+1,898,400
+37% +$158M 0.19% 67
2018
Q1
$456M Buy
5,116,100
+168,300
+3% +$16.2M 0.16% 83
2017
Q4
$516M Buy
4,947,800
+1,280,600
+35% +$144M 0.18% 73
2017
Q3
$535M Buy
3,667,200
+163,200
+5% +$22.2M 0.21% 67
2017
Q2
$455M Buy
3,504,000
+247,400
+8% +$30.3M 0.2% 81
2017
Q1
$405M Buy
3,256,600
+220,800
+7% +$26.4M 0.21% 76
2016
Q4
$351M Buy
3,035,800
+250,900
+9% +$27.9M 0.18% 89
2016
Q3
$291M Sell
2,784,900
-1,290,600
-32% -$140M 0.14% 109
2016
Q2
$402M Buy
4,075,500
+784,300
+24% +$81.1M 0.22% 69
2016
Q1
$329M Sell
3,291,200
-769,700
-19% -$79.3M 0.18% 88
2015
Q4
$486M Sell
4,060,900
-538,600
-12% -$62.3M 0.22% 66
2015
Q3
$498M Buy
4,599,500
+1,225,400
+36% +$152M 0.22% 68
2015
Q2
$391M Sell
3,374,100
-1,743,800
-34% -$199M 0.17% 86
2015
Q1
$590M Buy
5,117,900
+553,500
+12% +$66.1M 0.27% 41
2014
Q4
$511M Buy
4,564,400
+816,000
+22% +$86.1M 0.2% 72
2014
Q3
$355M Sell
3,748,400
-1,199,500
-24% -$108M 0.14% 110
2014
Q2
$425M Buy
4,947,900
+75,700
+2% +$5.76M 0.18% 74
2014
Q1
$340M Sell
4,872,200
-200,400
-4% -$15.9M 0.16% 93
2013
Q4
$429M Buy
5,072,600
+1,497,200
+42% +$118M 0.2% 68
2013
Q3
$275M Sell
3,575,400
-102,000
-3% -$7.15M 0.15% 90
2013
Q2
$215M Buy
+3,677,400
New +$221M 0.12% 111

Other funds holding CELG

Susquehanna International Group's CELG Position: Q4 2019 in Review

Susquehanna International Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,651,500 shares — an estimated $164M sold.

Susquehanna International Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $353M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Susquehanna International Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Susquehanna International Group sold 1,651,500 Celgene Corp shares in Q4 2019, an estimated $164M.
  • Susquehanna International Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Susquehanna International Group's Celgene Corp position peaked at $353M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.